Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Andrew

Finlay

,

CBE, FRCP

Clinical Professor
Cardiff University School of Medicine
Cardiff
,
United Kingdom
Councilor Since: January 1, 2006
IPC Councilor
Professor Andrew Finlay graduated in 1972 from St. Mary’s Hospital Medical School in London (where Fleming discovered penicillin). He has trained in London, Miami, and Cardiff, and was appointed consultant dermatologist in Glasgow in 1982. Moving back to Cardiff in 1987, he became Professor of Dermatology at Cardiff University from 1999 to 2009. He was President of the British Association of Dermatologists from 2000 to 2001 and appointed CBE in 2010. He pioneered the development of Quality of Life measures in dermatology, co-authoring the DLQI, CDLQI, FDLQI, CADI, and the partner/family measures FDLQI and FROM-16, that can be used across all specialties. He created the distance-learning Diploma in Practical Dermatology, which more than 200 general practitioners take annually. He was co-founder and editor of the Journal of Dermatological Treatment, has published more than 440 articles, and co-edited the 2022 book “Dermatology Training – The Essentials”.
Last Updated:
08/15/2024

Areas of Interest

Development of quality of life measurement techniques for patients and for partners/family members. Understanding influences on clinical decision taking, for example in out-patient management.

Languages Spoken

English

Involvement with Other Organization(s)

Serves on the advisory board of the International Alliance of Dermatology Patient Organisations; research in co-operation with Global Parents for Eczema research; member of the Psoriasis Association, United Kingdom.

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026